• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Crinetics Pharmaceuticals, Inc. - Common Stock (NQ: CRNX )

    53.60 +0.86 (+1.63%)
    Streaming Delayed Price Updated: 4:00 PM EST, Dec 20, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Crinetics Pharmaceuticals, Inc. - Common Stock

    < Previous 1 2 3 4 5 6 Next >
    Crinetics Pharmaceuticals Provides Update on CRN04777 Program
    From Crinetics Pharmaceuticals, Inc.
    Via GlobeNewswire
    Crinetics Pharmaceuticals to Participate in the 5th Annual Evercore ISI HealthCONx Conference
    From Crinetics Pharmaceuticals, Inc.
    Via GlobeNewswire
    Crinetics Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update
    From Crinetics Pharmaceuticals, Inc.
    Via GlobeNewswire
    Crinetics' CRN04777 Shows Dose-Dependent Suppression of Fasting Insulin
    Via Benzinga
    Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Crinetics Pharmaceuticals, Inc.
    Via GlobeNewswire
    Enrollment Completed in Phase 3 PATHFNDR-1 Study Evaluating Oral Paltusotine for the Treatment of Acromegaly
    Topline results for PATHFNDR-1 study expected in Q3 2023 
    From Crinetics Pharmaceuticals, Inc.
    Via GlobeNewswire
    Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Crinetics Pharmaceuticals, Inc.
    Via GlobeNewswire
    Innovation Passport Granted for CRN04777 for the Treatment of Congenital Hyperinsulinism
    From Crinetics Pharmaceuticals, Inc.
    Via GlobeNewswire
    Crinetics Pharmaceuticals Appoints Dana Pizzuti, M.D. as Chief Development Officer
    From Crinetics Pharmaceuticals, Inc.
    Via GlobeNewswire
    Crinetics Pharmaceuticals's Return On Capital Employed Overview
    Benzinga Pro data, Crinetics Pharmaceuticals (NASDAQ:CRNX) reported Q2 sales of $439 thousand. Earnings fell to a loss of $42.38 million, resulting in a 22.38% decrease from last quarter. 
    Via Benzinga
    Crinetics Pharmaceuticals: Q2 Earnings Insights
      Crinetics Pharmaceuticals (NASDAQ:CRNX) reported its Q2 earnings results on Friday, August 12, 2022 at 08:00 AM. Here's what investors need to know about the announcement. 
    Via Benzinga
    Crinetics Pharmaceuticals Announces Positive Top-line Results From CRN04894 Early-Stage Trial
    Crinetics Pharmaceuticals Inc (NASDAQ: CRNX) revealed positive topline results from a first-in-human Phase 1 clinical study of CRN04894 for the treatment of patients with Cushing's disease. 
    Via Benzinga
    The Daily Biotech Pulse: Third FDA Rejection For Verrica's Skin Disease Drug, Assembly Bio Terminates Hepatitis B Virus Pact, Consistency Data For Valneva's Chikungunya Vaccine
    Here's a roundup of top developments in the biotech space over the last 24 hours. 
    Via Benzinga
    88 Biggest Movers From Yesterday
    Gainers The Very Good Food Company Inc. (NASDAQ: VGFC) shares jumped 118.2% to close at $0.2950 on Wednesday as the company announced it increased retail distribution across Canada with Loblaw... 
    Via Benzinga
    The Daily Biotech Pulse: GlaxoSmithKline And Halozyme Go Shopping, Mylan's Insulin Glargine Recall, Turning Point Shares Lung Cancer Data And More
    Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Halozyme Buys Specialty Product Company Antares In $960M Deal 
    Via Benzinga
    53 Biggest Movers From Yesterday
    Gainers Longeveron Inc. (NASDAQ: LGVN) shares jumped 105.4% to close at $13.80 on Thursday after the company announced the publication of results from a Phase 1 trial testing... 
    Via Benzinga
    52 Biggest Movers From Yesterday
    Gainers Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) shares climbed 128.6% to close at $5.03 on Tuesday. The FDA approved expanded labeling for Cumberland... 
    Via Benzinga
    Exposures Product Safety
    12 Health Care Stocks Moving In Friday's Intraday Session
    Gainers iSpecimen (NASDAQ:ISPC) stock moved upwards by 115.09% to $21.94 during Friday's regular session. As of 12:30 EST, this security is trading at a volume of 62.8... 
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For November 30, 2021
    Upgrades Sidoti & Co. upgraded the previous rating for DMC Global Inc (NASDAQ: 
    Via Benzinga
    10 Biggest Price Target Changes For Monday
    Barclays cut Deciphera Pharmaceuticals, Inc. (NASDAQ: 
    Via Benzinga
    Last Week's Notable Insider Buys: Beacon Roofing Supply, Enfusion, Nerdy And More
    Insider buying can be an encouraging signal for potential investors, especially when markets are uncertain or near highs. Beneficial owners made some the most notable insider... 
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For November 23, 2021
    Upgrades Keefe, Bruyette & Woods upgraded the previous rating for CBRE Group Inc (NYSE: 
    Via Benzinga
    54 Biggest Movers From Yesterday
    Gainers Digital World Acquisition Corp. (NASDAQ: DWAC) shares climbed 356.8% to close at $45.50 on Thursday following an announcement the company will merge with Trump Media... 
    Via Benzinga
    Topics Government
    Exposures Political
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Gainers Sio Gene Therapies (NASDAQ:SIOX) stock moved upwards by 22.79% to $2.64 during Thursday's regular session. The current volume of 17.1 million shares is 2411.03... 
    Via Benzinga
    38 Stocks Moving In Thursday's Mid-Day Session
    Gainers Digital World Acquisition Corp. (NASDAQ: DWAC) shares jumped 132.3% to $23.14 following an announcement the company will merge with Trump Media & Technology Group.... 
    Via Benzinga
    Topics Government
    Exposures Political
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Gainers Sio Gene Therapies (NASDAQ:SIOX) shares rose 13.95% to $2.45 during Thursday's pre-market session. The market value of their outstanding shares is at $178.7... 
    Via Benzinga
    The Daily Biotech Pulse: FDA Authorizes Moderna, J&J Booster Shots; Regulatory Approvals For Bristol-Myers Squibb, Sanofi-Regeneron; Ventyx IPO
    Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus CDC Committee Recommends Approval Of Merck, Pfizer's Pneumococcal Vaccine... 
    Via Benzinga
    Exposures Product Safety
    Crinetics Spins Off Radiopharmaceuticals Efforts Into New Company
    Crinetics Pharmaceuticals Inc (NASDAQ: CRNX) spun out a new company, Radionetics, focused solely on a burgeoning field of radiopharmaceuticals.... 
    Via Benzinga
    The Daily Biotech Pulse: Leap, Phio, Silverback Among Early Movers On Oncology Conference Presentations, Aerie Slumps On Mixed Data, Axsome Commences Phase 3 Sleep Disorder Study
    Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 15) Alcon Inc. (NYSE: ALC)... 
    Via Benzinga
    The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization
    Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 8) Abbott Laboratories (NYSE:... 
    Via Benzinga
    Exposures COVID-19
    < Previous 1 2 3 4 5 6 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.